LIFESOME THERAPEUTICS
Contact information
- Drug delivery
- Drug development
- Cosmetics
- Dermatology
- Infectious diseases
- Inflammatory diseases
- Oncology
- Central nervous system
- Animal health / Veterinary
- Food safety
Lifesome Therapeutics S.L. is a nanotechnology startup dedicated to the synthesis and formulation of the first generation of drug delivery vectors with intrinsic therapeutic properties on the market.
Our proprietary technology, supported by numerous scientific studies, demonstrates its exceptional potential to be used in advanced therapies against cancer and bacterial infections. We are currently also working to extend its reach to other therapeutic areas, such as gene therapy and theragnostic tools (simultaneous diagnosis + therapy).
Lifesome Therapeutics S.L. sells a novel nanotechnological product, named Ohmline, which self-assembles into drug delivery nanovectors. These vectors are structures capable of transporting and releasing drugs in a controlled manner, directly into their site of action, significantly reducing adverse effects. Moreover, Ohmline exerts a unique feature which differentiates it from other nanovectors on the market: it has intrinsic therapeutic activity, which allows the rational design of therapeutic combinations that increase the efficacy of the encapsulated drug. Whereas vectors from our competitors are mainly passive agents, only transporting the drug towards its site of action, Ohmline by itself (without any associated drug) has shown antitumoral and antimetastatic activities in both in vitro cell models (prostate and colorectal cancer) and in vivo mouse models (breast cancer). Besides, Ohmline has shown antibiotic activity in vitro. Preliminary toxicology studies in cells and animal models have shown that their toxicity is almost null.
Our services include encapsulation of drugs in Ohmline-derived nanovectors to identify synergies that can improve the efficacy and safety of said drugs. Noteworthy, Ohmline-derived nanovectors can be formulated in a wide array of different 3D conformations, such as nanotubes, nanoparticles, hydrogels or nanomaterial for 3D printing. This considerably widens the number of drugs that can be encapsulated, as well as their therapeutic applications.
Finally, Lifesome not only offers this new technology, but also provides technical support and expertise within collaborations with public and private research institutions.
Cancer, bacterial infections (human health and veterinary sciences), gene therapy.